Mandadi Tilak 4

What Happened

Tilak Mandadi, EVP and Chief Experience & Technology Officer at CVS Health (CVS), sold 69,551 shares in an open-market disposition on May 8, 2026. The reported per-share figure on the Form 4 is $89.58; a filing footnote states the shares were sold at an average price between $89.30 and $89.81, for total proceeds of approximately $6,230,379. This was a sale (transaction code S), a routine insider disposition rather than a purchase.

Key Details

• Transaction date: May 8, 2026 (open-market sale).
• Reported price: $89.58 per share (footnote F1: average price range $89.30–$89.81).
• Shares sold: 69,551 ; proceeds ≈ $6,230,379.
• Shares owned after transaction: Not provided in the data supplied.
• Filing date: May 11, 2026 — appears timely (filed within the SEC’s reporting window).
• Footnotes: F1 notes the average sale price range; transaction listed as open market/private sale (S).

Context

Sales by company insiders are common and can reflect many personal or tax-planning reasons; they do not by themselves indicate the insider’s view of the company’s prospects. Purchases are generally more informative about confidence in future performance. This filing documents a single large sale and was filed promptly per the provided dates.